Early changes in soluble intracellular adhesion molecule‐1 as prognostic biomarkers to immune checkpoint inhibitor

• Κύριοι συγγραφείς: Dongmei Ji (Συγγραφέας), Shiyu Jiang (Συγγραφέας), Qunling Zhang (Συγγραφέας), Y. Ken Wang (Συγγραφέας), Jian Zhang (Συγγραφέας), Weina Shen (Συγγραφέας), Wenhua Li (Συγγραφέας), Rujiao Liu (Συγγραφέας), Jessica Wang (Συγγραφέας), Cory Mavis (Συγγραφέας), Juan J. Gu (Συγγραφέας), Xichun Hu (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Wiley, 2023-08-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Serologic biomarker to predict clinical outcome is needed for immune checkpoint inhibitors (ICIs). We evaluated soluble intercellular adhesion molecules‐1 (sICAM‐1) as a predictor of response to ICIs treatment. Ninety‐five patients with cancer treated with ICI were studied. The serum sICAM‐...